Novelix Pharmaceuticals Ltd — Insider Trading, 08-12-2025: Insider Trading / SAST

Novelix Pharmaceuticals has announced a board meeting on December 11, 2025, to consider a proposal for fund raising. This could involve issuing permissible securities through a preferential issue or other modes. Alongside this, the company has closed its trading window for Designated Persons and their relatives, effective from December 08, 2025. The window will reopen 48 hours after the meeting's outcome is disclosed to the stock exchanges. This measure helps prevent insider trading ahead of potentially market-moving financial decisions.